Search Results 311-320 of 16965 for Hepatotoxicity
View clinical trials, clinical studies and funding information for Mayo Clinic's Genomic and Exposomic Hepatobiology Lab led by Konstantinos N. Lazaridis, ...
In most cases, Mayo Clinic doesn't require a physician referral. Some insurers require referrals, or may have additional requirements for certain medical care.
About this study. The purpose of this study is to evaluate the safety and effectiveness, as determined by 90-day incidence of mortality or transplant, ...
Video: A healthy liver transitions to cirrhosis, illustrating a potential outcome of metabolic dysfunction-associated steatotic liver disease — formerly known ...
The purpose of this study is to examine the changes in the gut microbiome of patients before and after liver transplantation, including the donor organ ...
The purpose of the study is to evaluate the safety of Rifaximin or placebo in subjects with severe hepatic impairment and Hepatic Encephalopathy. Participation ...
About this study. This research study is for liver transplant recipients and their respective living donors. The purpose of this study is to see if it is ...
99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.